Infusions, Intravenous
"Infusions, Intravenous" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it.
Descriptor ID |
D007262
|
MeSH Number(s) |
E02.319.267.082.500 E02.319.267.510.590
|
Concept/Terms |
Intravenous Drip- Intravenous Drip
- Drip, Intravenous
- Drip Infusions
- Drip Infusion
- Infusion, Drip
- Infusions, Drip
|
Below are MeSH descriptors whose meaning is more general than "Infusions, Intravenous".
Below are MeSH descriptors whose meaning is more specific than "Infusions, Intravenous".
This graph shows the total number of publications written about "Infusions, Intravenous" by people in this website by year, and whether "Infusions, Intravenous" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1992 | 0 | 3 | 3 | 1993 | 0 | 7 | 7 | 1994 | 0 | 7 | 7 | 1995 | 0 | 1 | 1 | 1996 | 0 | 4 | 4 | 1997 | 0 | 2 | 2 | 1998 | 1 | 8 | 9 | 1999 | 0 | 5 | 5 | 2000 | 0 | 2 | 2 | 2001 | 0 | 5 | 5 | 2002 | 0 | 4 | 4 | 2003 | 0 | 8 | 8 | 2004 | 0 | 11 | 11 | 2005 | 0 | 7 | 7 | 2006 | 0 | 9 | 9 | 2007 | 0 | 14 | 14 | 2008 | 0 | 6 | 6 | 2009 | 0 | 8 | 8 | 2010 | 1 | 11 | 12 | 2011 | 0 | 7 | 7 | 2012 | 0 | 5 | 5 | 2013 | 0 | 7 | 7 | 2014 | 0 | 14 | 14 | 2015 | 0 | 3 | 3 | 2016 | 0 | 5 | 5 | 2017 | 0 | 6 | 6 | 2018 | 0 | 16 | 16 | 2019 | 1 | 7 | 8 | 2020 | 0 | 4 | 4 | 2021 | 0 | 5 | 5 | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Infusions, Intravenous" by people in Profiles.
-
Henthorn TK, Krejcie TC, Avram MJ. Elimination Clearance of Dexmedetomidine: Cross-examining What the Data Say. Anesthesiology. 2022 02 01; 136(2):258-260.
-
Eggermont AM, Ascierto PA, Khushalani NI, Schadendorf D, Boland G, Weber J, Lewis KD, Johnson D, Rivalland G, Khattak A, Majem M, Gogas H, Long GV, Currie SL, Chien D, Tagliaferri MA, Carlino MS, Diab A. PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence. Future Oncol. 2022 Mar; 18(8):903-913.
-
Chang EI, Hetrick B, Wesolowski SR, McCurdy CE, Rozance PJ, Brown LD. A Two-Week Insulin Infusion in Intrauterine Growth Restricted Fetal Sheep at 75% Gestation Increases Skeletal Myoblast Replication but Did Not Restore Muscle Mass or Increase Fiber Number. Front Endocrinol (Lausanne). 2021; 12:785242.
-
Leasia KN, Ciarallo C, Prins JTH, Preslaski C, Perkins-Pride E, Hardin K, Cralley A, Burlew CC, Coleman JJ, Cohen MJ, Lawless R, Platnick KB, Moore EE, Pieracci FM. A randomized clinical trial of single dose liposomal bupivacaine versus indwelling analgesic catheter in patients undergoing surgical stabilization of rib fractures. J Trauma Acute Care Surg. 2021 11 01; 91(5):872-878.
-
Korley FK, Durkalski-Mauldin V, Yeatts SD, Schulman K, Davenport RD, Dumont LJ, El Kassar N, Foster LD, Hah JM, Jaiswal S, Kaplan A, Lowell E, McDyer JF, Quinn J, Triulzi DJ, Van Huysen C, Stevenson VLW, Yadav K, Jones CW, Kea B, Burnett A, Reynolds JC, Greineder CF, Haas NL, Beiser DG, Silbergleit R, Barsan W, Callaway CW. Early Convalescent Plasma for High-Risk Outpatients with Covid-19. N Engl J Med. 2021 11 18; 385(21):1951-1960.
-
Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, Gabra N, Ramirez JA, Thai C, Chege W, Gomez Lorenzo MM, Sista N, Farrior J, Clement ME, Brown ER, Custer KL, Van Naarden J, Adams AC, Schade AE, Dabora MC, Knorr J, Price KL, Sabo J, Tuttle JL, Klekotka P, Shen L, Skovronsky DM. Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial. JAMA. 2021 07 06; 326(1):46-55.
-
Rosas IO, Bräu N, Waters M, Go RC, Hunter BD, Bhagani S, Skiest D, Aziz MS, Cooper N, Douglas IS, Savic S, Youngstein T, Del Sorbo L, Cubillo Gracian A, De La Zerda DJ, Ustianowski A, Bao M, Dimonaco S, Graham E, Matharu B, Spotswood H, Tsai L, Malhotra A. Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia. N Engl J Med. 2021 04 22; 384(16):1503-1516.
-
Kanni T, Argyropoulou M, Dinarello CA, Simard J, Giamarellos-Bourboulis EJ. MABp1 targeting interleukin-1a in hidradenitis suppurativa ineligible for adalimumab treatment: results of the open-label extension period. Clin Exp Dermatol. 2021 Jan; 46(1):162-163.
-
Gralow JR, Barlow WE, Paterson AHG, M'iao JL, Lew DL, Stopeck AT, Hayes DF, Hershman DL, Schubert MM, Clemons M, Van Poznak CH, Dees EC, Ingle JN, Falkson CI, Elias AD, Messino MJ, Margolis JH, Dakhil SR, Chew HK, Dammann KZ, Abrams JS, Livingston RB, Hortobagyi GN. Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307. J Natl Cancer Inst. 2020 07 01; 112(7):698-707.
-
Minard-Colin V, Aupérin A, Pillon M, Burke GAA, Barkauskas DA, Wheatley K, Delgado RF, Alexander S, Uyttebroeck A, Bollard CM, Zsiros J, Csoka M, Kazanowska B, Chiang AK, Miles RR, Wotherspoon A, Adamson PC, Vassal G, Patte C, Gross TG. Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children. N Engl J Med. 2020 06 04; 382(23):2207-2219.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|